–6th Orphan Drug Designation granted to toripalimab in the US and EU SHANGHAI, China, July 21, 2022 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced today that toripalimab, a PD-1 inhibitor independently developed […]

Read More

DARWIN, Australia, July 21, 2022 (GLOBE NEWSWIRE) — Aboriginal and Torres Strait Islander creatives will be celebrated in Darwin, Australia, from 2-7 August in an unmissable showcase of art, design and culture at Darwin Aboriginal Art Fair (DAAF) Foundation’s series of iconic events. The Darwin Aboriginal Art Fair (DAAF) is Australia’s largest and most celebrated […]

Read More